Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study

scientific article

Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/OTT.S102433
P932PMC publication ID4869662
P698PubMed publication ID27274271

P50authorWenjin YinQ83588070
P2093author name stringJinsong Lu
Yiwei Jiang
Qiong Zhou
Yaohui Wang
P2860cites workMenopausal Estrogens and Breast CancerQ39997555
Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activationQ40124678
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.Q40168734
MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structureQ41228757
Heparan sulfate proteoglycans as transducers of FGF-2 signalling.Q41433792
Transcriptome-wide analysis of UTRs in non-small cell lung cancer reveals cancer-related genes with SNV-induced changes on RNA secondary structure and miRNA target sitesQ41860003
Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancerQ46976199
Exemestane for breast-cancer prevention in postmenopausal womenQ48657440
Ras/MEK/MAPK-mediated regulation of heparin sulphate proteoglycans promotes retinal fate in the Drosophila eye-antennal disc.Q50592903
Association of the SNP rs2623047 in the HSPG modification enzyme SULF1 with an Australian Caucasian breast cancer cohort.Q54204332
Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury.Q54321477
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenQ57752001
The risk of breast cancer after estrogen and estrogen-progestin replacementQ69352496
A case-control study of menopausal estrogen therapy and breast cancerQ71146106
An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onsetQ84595786
HSulf-1 inhibits angiogenesis and tumorigenesis in vivoQ24293660
Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survivalQ24310871
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cellsQ24338405
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancerQ24523684
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeQ24646090
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistanceQ24679991
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsiesQ27497347
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast CancerQ28142158
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 studyQ28281843
Mechanisms of gene silencing by double-stranded RNAQ28282560
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyQ28283241
mTOR Complex Component Rictor Interacts with PKCζ and Regulates Cancer Cell MetastasisQ28296765
The evolution of gene regulation by transcription factors and microRNAsQ29617552
Genetic analysis of genome-wide variation in human gene expressionQ29617852
microRNAs as oncogenes and tumor suppressorsQ29619907
TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cellsQ33373526
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer riskQ34072975
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.Q34189632
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancerQ34515500
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation.Q34712217
miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancerQ34791023
Estrogen receptor mutations in human diseaseQ35975453
Epigenetic information and estrogen receptor alpha expression in breast cancerQ36364262
Micromanagers of malignancy: role of microRNAs in regulating metastasisQ37233362
Involvement of microRNAs in breast cancer.Q37308235
MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.Q37330900
Dysregulation of microRNAs in cancer: playing with fireQ37779828
Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.Q38303667
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialQ38406470
The RNAsnp web server: predicting SNP effects on local RNA secondary structureQ38633418
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer.Q39369234
Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesisQ39393558
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectsingle-nucleotide polymorphismQ501128
P304page(s)2749-2757
P577publication date2016-05-09
P1433published inOncoTargets and TherapyQ7092081
P1476titleSingle-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study
P478volume9

Search more.